Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study design has two components: 1) a cross-sectional assessment of brain activity and inflammation in migraine patients compared to healthy controls and 2) an assessment of 8 weeks of a combination therapy approach to treating migraine.
Full description
Chronic pain is the most prevalent and disabling medical condition, and no single therapy has proven to be completely successful for alleviating pain, such as migraine headache. It is well documented, and recommended in the recent Institute of Medicine (IOM) report, that a multimodal approach is optimal for pain management. This study will evaluate a combination transcutaneous vagus nerve stimulation and stress reduction training for migraine.
Investigators will recruit participants who have migraines and randomize to one of four potential treatment arms (real or sham stimulation + real or sham stress reduction training). Brain imaging (MRI and PET) and clinical data will be collected before and after 8 weeks of the combination therapy.
Healthy controls will also be recruited for collection of the same baseline brain imaging and clinical data, but with no treatment or second data collection phase.
Findings from this research will help elucidate brain activity and inflammation associated with migraines and evaluate the efficacy of the combination therapy in reducing migraine.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Healthy Volunteers between the ages of 18 and 65 can participate in this study.
Exclusion criteria
Healthy Volunteers have the same eligibility constraints with the addition of current or past history of migraine.
Primary purpose
Allocation
Interventional model
Masking
193 participants in 4 patient groups
Loading...
Central trial contact
Kassandra Round
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal